Σοφ. Βενιζέλου 114, Χαλάνδρι - Τ.: 2106719422
The US Food and Drug Administration (FDA) has approved tirzepatide for chronic weight management in adults with obesity or overweight. Eli Lilly & Company will market tirzepatide injections for weight management under the trade name Zepbound. It was approved in May 2022 for treating type 2 diabetes. The new indication is for adults with either…
Rod Tucker 19 June 2023 With increasing evidence that cannabis use is associated with adverse cardiovascular effects, questions are undoubtedly being asked about the safety of the drug for medical uses. Rod Tucker investigates. Cardiovascular risks For several states in the US and many other countries such as Canada, use of recreational cannabis has been…
Rod Tucker 20 October 2023 Air pollution contains particulate matter that can carry antibiotic resistance genes, which have been found to accelerate microbial threats to human health. Here, Rod Tucker considers the extent to which air pollution could serve as a primary vector and driving force behind the increasing levels of global antibiotic resistance.